The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
941 MANNITOL MANNITOL 20G/100ML INFUSION Sachet OSMOTIC DIURETIC NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 12 L 0354/99 29-Sep-2022 28-Sep-2025 View
942 MEFENAMIC 500 MEFENAMIC ACID 500MG TABLET BLISTER NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 03 L 0826/20 31-JUL-2023 30-JUL-2026 View
943 MENDAZOL MEBENDAZOLE 100 MG/5 ML SUSPENSION bottle NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 12 L 0790/19 11-SEP-2023 10-SEP-2026 View
944 MENDAZOL MEBENDAZOL 500MG TABLET BLISTERPACK NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 07 L 0306/98 24-SEP-2024 23-SEP-2027 View
945 MEPRAZOL OMEPRAZOL 20MG CAPSULE BLISTERPACK FOR THE TRETMENT OF DUODENAL ULCER, GASTRIC ULCER, REFLUX OESOPHAGITIS. NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 11 L 0421/02 24-SEP-2024 23-SEP-2027 View
946 MERGOTRINE METHYLERGOMETRINE MALEATE 0.2MG INJECTION AMPOULES - NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 12 L 0359/99 12-Aug-2022 11-Aug-2025 View
947 METOCLOPRAMIDE METOCLOPRAMIDE HYDROCHLORIDE 10MG TABLET BLISTERPACK NAUSEA AND VOMITTING… NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 08 L 0140/95 12-Aug-2022 11-Aug-2025 View
948 METRODYL 500 METRONIDAZOL 500 MG TABLET BLISTERPACK TREATMENT OF PREVENTION OF INFECTION CAUSED BY SUSCEPTIBLE ANAEROBIC BACTERIA, TRICHOMONASIS, AMOEBIASIS NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 10 L 0886/21 03-FEB-2025 02-FEB-2030 View
949 METRONIDAZOLE METRONIDAZOL 250 MG TABLET BLISTERPACK NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 06 L 0297/98 24-SEP-2024 23-SEP-2027 View
950 MORPHINE MORPHINE 10 MG/1ML INJECTION AMPOULES NARCOTIC ANALGESIC IN SEVERE CASE USE NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 01 L 0677/16 05-Apr-2023 04-Apr-2026 View